Co-careldopa (Carbidopa/levodopa) Prescribing at THE DE PARYS GROUP
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
955
Total Quantity
117.2K
NHS Cost
£11.1K
vs National Avg
+322.6%
THE DE PARYS GROUP prescribed 955 items of Co-careldopa (Carbidopa/levodopa) over the last 12 months at a cost of £11,051 to the NHS. This is 322.6% above the national average prescribing rate. Co-careldopa (Carbidopa/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jul 2026
75
Jul 2026
88
Jul 2026
76
Jul 2026
81
Jul 2026
74
Jul 2026
91
Jul 2026
78
Jul 2026
83
Jul 2026
76
Jul 2026
69
Jul 2026
76
Jul 2026
88
Prescribing Details
| Total Items | 955 |
|---|---|
| Total Quantity | 117,184 |
| Total NHS Cost | £11,051 |
| Presentations | 9 different forms |
| vs National Average | +322.6% |
Co-careldopa (Carbidopa/levodopa) Prescribing Comparison
| This practice | 955 items |
|---|---|
| National average per practice | 226 items |
| Difference | +322.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.